Liposuction for lipomas.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 4056191)

Published in J Dermatol Surg Oncol on November 01, 1985

Authors

R Rubenstein, H H Roenigk, J M Garden, N S Goldberg, J B Pinski

Articles by these authors

Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05

Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00

Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80

Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion (2000) 2.52

Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol (1986) 1.95

Autologous fat transplantation. Long-term follow-up. J Dermatol Surg Oncol (1992) 1.88

In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol (1984) 1.80

Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol (1985) 1.75

Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc Natl Acad Sci U S A (1986) 1.75

Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J Gen Virol (1986) 1.67

Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol (1971) 1.57

Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology (1994) 1.50

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49

Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol (1991) 1.48

Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45

Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. Blood (1996) 1.44

The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med (1996) 1.42

Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol (1993) 1.41

Erythema gyratum repens in a healthy woman. J Am Acad Dermatol (1992) 1.38

Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol (1987) 1.35

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging (2001) 1.31

Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30

Estrogen-induced porphyria cutanea tarda. Report of three cases. Arch Dermatol (1970) 1.30

Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser. Dermatol Surg (1999) 1.25

Immunohistochemical detection of prion protein in sheep with scrapie. J Vet Diagn Invest (1993) 1.20

Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol (1986) 1.12

Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA (1992) 1.12

Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection. Arch Dermatol (1991) 1.11

Mites as vectors for scrapie. Lancet (1996) 1.11

Hydroa vacciniforme. Diagnosis by repetitive ultraviolet-A phototesting. Arch Dermatol (1986) 1.10

Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience (2005) 1.10

Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica (1987) 1.08

Ischemic stroke associated with methamphetamine inhalation. Neurology (1988) 1.07

Detection of prion protein in formalin-fixed brain by hydrated autoclaving immunohistochemistry for the diagnosis of scrapie in sheep. J Vet Diagn Invest (1994) 1.07

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA (1975) 1.06

Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst (1990) 1.05

Methotrexate guidelines--revised. J Am Acad Dermatol (1982) 1.04

Use of methotrexate in psoriasis. Arch Dermatol (1972) 1.04

Current surgical management of skin cancer in dermatology. J Dermatol Surg Oncol (1990) 1.03

Annular elastolytic giant cell granuloma. A clinicopathologic study of five cases and a review of similar entities. J Am Acad Dermatol (1979) 1.02

Retin-A and wax epilation. Arch Dermatol (1989) 1.02

Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Am Acad Dermatol (1997) 1.01

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods (2000) 1.00

Paired helical filaments associated with Alzheimer disease are readily soluble structures. Brain Res (1986) 1.00

Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol (1971) 0.99

Clinical and molecular genetic study of a large German kindred with Gerstmann-Sträussler-Scheinker syndrome. Neurology (1991) 0.99

Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol (1986) 0.99

Malignant lymphoma presenting with cutaneous granulomas. J Am Acad Dermatol (1984) 0.98

Facial and scalp lipomas: case reports and study of prevalence. J Dermatol Surg Oncol (1985) 0.97

Photochemotherapy for mycosis fungoides. Arch Dermatol (1977) 0.97

Lichen myxedematosus. An unusual case with rapid progression and possible internal involvement. Int J Dermatol (1987) 0.97

Immunodiagnosis of prion disease. Immunol Invest (1997) 0.96

CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am J Physiol (1999) 0.95

Surgical management of leg ulcers. Dermatol Clin (1987) 0.95

Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst (1990) 0.95

Immunotherapy of malignant melanoma with vaccinia virus. Arch Dermatol (1974) 0.95

Histiocytosis X. Flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol (1986) 0.94

Effect of dye laser pulse duration on selective cutaneous vascular injury. J Invest Dermatol (1986) 0.93

Tumor cell characterization in mycosis fungoides. Cancer (1976) 0.93

Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol (1995) 0.93

Dermatologic manifestations of gastrointestinal disorders. Gastroenterol Clin North Am (1998) 0.93

Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am (1995) 0.92

Detection of scrapie-associated fibrils (SAF) and SAF proteins from scrapie-affected sheep. J Infect Dis (1987) 0.92

Meningococcal meningitis with a benign skin rash. Pediatr Dermatol (1986) 0.91

Mycosis fungoides: time to define the best therapy. J Natl Cancer Inst (1990) 0.91

The double scalpel and double punch excision of skin tumors. J Am Acad Dermatol (1982) 0.91

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol (1991) 0.89

Human bite marks. Differential diagnosis. Clin Pediatr (Phila) (1989) 0.89

Pulsed dye laser (577 nm) treatment of portwine stains: ultrastructural evidence of neovascularization and mast cell degranulation in healed lesions. J Invest Dermatol (1988) 0.88

The solubility controversy of paired helical filaments: a commentary. Neurochem Res (1987) 0.88

Skin lesions of the spinal axis and spinal dysraphism. Fifteen cases and a review of the literature. Arch Pediatr Adolesc Med (1994) 0.88

Pruritus in hepatic cholestasis. Pathogenesis and therapy. Arch Dermatol (1985) 0.88

Characteristics of scrapie isolates derived from hay mites. J Neurovirol (2000) 0.88

Tattooing--history, technics, complications, removal. Cleve Clin Q (1971) 0.88

Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep (1979) 0.88

Herpes simplex virus infection of isolated autonomic neurons in culture: viral replication and spread in a neuronal network. Arch Virol (1982) 0.87

Hair casts: classification, staining characteristics, and differential diagnosis. J Am Acad Dermatol (1983) 0.87

Localized scleroderma. Arch Dermatol (1975) 0.87

Autoerythrocyte sensitization syndrome (psychogenic purpura). J Am Acad Dermatol (1992) 0.86

Methotrexate therapy for psoriasis. Guideline revisions. Arch Dermatol (1973) 0.86

Selective immunological evaluation of mycosis fungoides. Arch Dermatol (1978) 0.86

Necrotizing vasculitis (erythema elevatum diutinum). Arch Dermatol (1971) 0.86

The cutaneous mucinoses. J Am Acad Dermatol (1986) 0.86

The puzzle of PrPSc and infectivity--do the pieces fit? Trends Neurosci (1994) 0.85

Laser treatment of pigmented lesions and tattoos. Semin Cutan Med Surg (2000) 0.85

Evidence for biological and structural diversity among scrapie strains. Curr Top Microbiol Immunol (1991) 0.85

Plane xanthoma and multiple myeloma with lipoprotein--paraprotein complexing. Arch Dermatol (1978) 0.85

Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol (1986) 0.84

The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. Postgrad Med (1980) 0.84

Psychosocial functioning in the Ehlers-Danlos syndrome. Am J Med Genet (1994) 0.84

Degos' disease (malignant papulosis). Report of three cases with clues to etiology. JAMA (1968) 0.84

Essential primary cutis verticis gyrata. Treatment with the scalp reduction procedure. Arch Dermatol (1984) 0.84

Mycophenolic acid for psoriasis. Arch Dermatol (1977) 0.84

The nature of the scrapie agent. Biological characteristics of scrapie in different scrapie strain-host combinations. Ann N Y Acad Sci (1994) 0.83

Porphyria cutanea tarda. Association with abnormal iron metabolism. Arch Dermatol (1965) 0.83

Bowen's disease of the distal digit. Outcome of treatment with carbon dioxide laser vaporization. Dermatol Surg (1996) 0.83